Aerie Pharmaceuticals (United States)

Aerie Pharmaceuticals (United States)

Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Aerie Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

68%


Total
Publications

62


Total Open
Publications

42


Total
Citations

2.6K


Open Access
Percentage

68%


Total
Publications

62


Total Open
Publications

42


Total
Citations

2.6K

Wikipedia

Website

download

Breakdown

23% 34% 11% 32%

Publisher Open

23%

Both

34%

Other Platform Open

11%

Closed

32%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

012345678910Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

20%OA Journal

OA Journal 20%

7

Hybrid 60%

21

No Guarantees 20%

7

Other Platform Open

Domain 82%

23

Preprint 18%

5

Public 14%

4

Other Internet 14%

4

Institution 7%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
23
Europe PMC
Domain
10
bioRxiv
Preprint
4
Semantic Scholar
Public
3
DOI
Other Internet
2
California Digital Library - eScholarship
Other Internet
2
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
1
University of California - eScholarship University of California
Institution
1
RePEc: Research Papers in Economics - RePEc
Preprint
1
Figshare
Public
1
1 / 1

Data updated 7 October 2024

Share

Share

Share